We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical, Neurophysiological and Radiological Evaluation of Patients With Basal Ganglia Lesions

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00169325
First Posted: September 15, 2005
Last Update Posted: September 14, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Marie-laure Welter, Groupe Hospitalier Pitie-Salpetriere
  Purpose
Basal ganglia are involved in the control of motor, cognitive and emotional behaviours. The aim of this study is to precisely evaluate patients with basal ganglia focal lesions both with or without loss of psychic-self activation.

Condition Intervention
Basal Ganglia Lesions Procedure: Magnetic resonance imaging

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Further study details as provided by Marie-laure Welter, Groupe Hospitalier Pitie-Salpetriere:

Enrollment: 11
Study Start Date: September 2005
Study Completion Date: January 2014
Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients with lesion of the basal ganglia structures
Criteria

Inclusion Criteria:

  • Basal ganglia lesions

Exclusion Criteria:

  • Contraindication to magnetic resonance imaging (MRI)
  • Dementia
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00169325


Locations
France
Centre d'Investigation Clinique-Hôpital Pitié-Salpetriere
Paris, France
Sponsors and Collaborators
Marie-laure Welter
Investigators
Principal Investigator: Bruno Dubois, MD, PhD Groupe Hospitalier Pitié-Salpêtrière
  More Information

Responsible Party: Marie-laure Welter, MD, PhD, Groupe Hospitalier Pitie-Salpetriere
ClinicalTrials.gov Identifier: NCT00169325     History of Changes
Other Study ID Numbers: P031201
First Submitted: September 12, 2005
First Posted: September 15, 2005
Last Update Posted: September 14, 2015
Last Verified: September 2015

Keywords provided by Marie-laure Welter, Groupe Hospitalier Pitie-Salpetriere:
basal ganglia
loss of psychic self-activation

Additional relevant MeSH terms:
Ganglion Cysts
Synovial Cyst
Cysts
Neoplasms
Mucinoses
Connective Tissue Diseases